Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta‐Analysis of Randomized Trials
Critical Care Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ccrp/5581019 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Critical Care Research and Practice, online erschienen am 24.03.2026. Verfasst von Jinlu Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Intensive Care Unit, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Te…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess the safety and efficacy of prophylactic proton pump inhibitors (PPIs) among critically ill adults undergoing invasive ventilation.
Methods
We systematically searched PubMed, Web of Science, Embase, and the Cochrane Library for randomized controlled trials (RCTs) published up to September 19, 2024. Eligible trials compared prophylactic PPIs with placebo or no prophylaxis for upper gastrointestinal bleeding (UGIB) prevention in adults receiving invasive ventilation. Nine RCTs encompassing 8388 patients were included. Data were pooled using Review Manager 5.4, with a random‐effects model applied to all outcomes.
Results
All‐cause mortality rates were comparable between the PPI and control groups (odds ratio [OR]: 0.98; 95% confidence interval [CI]: 0.89−1.07; I 2 = 0%; p = 0.61). PPI prophylaxis significantly reduced the incidence of UGIB (OR: 0.42; 95% CI: 0.23−0.75; I 2 = 33%; p = 0.003) and clinically important UGIB (OR: 0.36; 95% CI: 0.19−0.69; I 2 = 10%; p = 0.002). The analysis revealed no significant increase in the risk of ventilator‐associated pneumonia (OR, 0.99; 95% CI, 0.87 to 1.12; I 2 = 0%; p = 0.86) or Clostridioides difficile infection (OR, 1.63; 95% CI, 0.97 to 2.73; I 2 = 0%; p = 0.07) with PPI use. Durations of intensive care unit stay and invasive ventilation did not differ significantly between groups.
Conclusion
Among mechanically ventilated patients, prophylactic PPI therapy significantly decreased UGIB and clinically important UGIB risk compared to placebo, without affecting all‐cause mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Adult Intensive Care Unit, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China, uestc.edu.cn.
ORCID-Profile: Jinlu Hu, Haiyan Ye, Bo Li, Xuemei Zheng
Zitieren
APA
Hu, J., Ye, H., Li, B., & Zheng, X. (2026). Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta‐Analysis of Randomized Trials. Critical Care Research and Practice, 2026(1). https://doi.org/10.1155/ccrp/5581019
Vancouver
Hu J, Ye H, Li B, Zheng X. Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta‐Analysis of Randomized Trials. Critical Care Research and Practice. 2026;2026(1). doi:10.1155/ccrp/5581019
BibTeX
@article{Hu2026,
author = {Hu, Jinlu and Ye, Haiyan and Li, Bo and Zheng, Xuemei},
title = {Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta‐Analysis of Randomized Trials},
journal = {Critical Care Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ccrp/5581019}
}
EUVIMED